Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer

• Principais autores: Feng Guan (Autor), Xianli Ju (Autor), Lixia Chen (Autor), Jiacai Ren (Autor), Xiaokang Ke (Autor), Bin Luo (Autor), Aoling Huang (Autor), Jingping Yuan (Autor)
• Formato: Livro
• Publicado em: BMC, 2024-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background This study aims to analyze potential differences in clinicopathology, efficacy of neoadjuvant therapy (NAT), and clinical outcome among HER2-null, HER2-ultralow and HER2-low breast cancers. Methods Consecutive cases of HER2-negative breast cancer that received NAT were included....